Search research articles
Contact Us
Filters
Showing results (1231-1240 of 1,421) with videos related to
Page
of 143
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2024
Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice
Debra L Richardson, Julia C F Quintanilha, Natalie Danziger, et al.
Calcified Tissue International
|
December 6, 2018
Trauma-Induced Nanohydroxyapatite Deposition in Skeletal Muscle is Sufficient to Drive Heterotopic Ossification
Stephanie N Moore-Lotridge, Qiaoli Li, Breanne H Y Gibson, et al.
Targeted Oncology
|
September 24, 2021
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
Kathleen N Moore, David S Hong, Manish R Patel, et al.
Gynecologic Oncology
|
June 15, 2020
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer
Kathleen N Moore, Michael J Birrer, Jim Marsters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2023
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer
Sandra J Casak, M Naomi Horiba, Mengdie Yuan, et al.
Prostate Cancer and Prostatic Diseases
|
July 23, 2021
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
Miguel Gonzalez Velez, Heidi E Kosiorek, Jan B Egan, et al.
Journal of Pediatric Orthopedics
|
October 10, 2018
C-Reactive Protein Predicts Risk of Venous Thromboembolism in Pediatric Musculoskeletal Infection
Emilie Amaro, Tanya K Marvi, Samuel L Posey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2020
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
William P Tew, Christina Lacchetti, Annie Ellis, et al.
Neurology
|
November 23, 2005
Seizure focus affects regional language networks assessed by fMRI
M M Berl, L M Balsamo, B Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2022
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study
Benoit You, Vasudha Sehgal, Balakrishna Hosmane, et al.
Page
of 143
Search research articles
Search
Showing results (1231-1240 of 1,421) with videos related to
Sort By:
Page
of 143
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2024
Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice
Debra L Richardson, Julia C F Quintanilha, Natalie Danziger, et al.
Calcified Tissue International
|
December 6, 2018
Trauma-Induced Nanohydroxyapatite Deposition in Skeletal Muscle is Sufficient to Drive Heterotopic Ossification
Stephanie N Moore-Lotridge, Qiaoli Li, Breanne H Y Gibson, et al.
Targeted Oncology
|
September 24, 2021
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
Kathleen N Moore, David S Hong, Manish R Patel, et al.
Gynecologic Oncology
|
June 15, 2020
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer
Kathleen N Moore, Michael J Birrer, Jim Marsters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2023
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer
Sandra J Casak, M Naomi Horiba, Mengdie Yuan, et al.
Prostate Cancer and Prostatic Diseases
|
July 23, 2021
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
Miguel Gonzalez Velez, Heidi E Kosiorek, Jan B Egan, et al.
Journal of Pediatric Orthopedics
|
October 10, 2018
C-Reactive Protein Predicts Risk of Venous Thromboembolism in Pediatric Musculoskeletal Infection
Emilie Amaro, Tanya K Marvi, Samuel L Posey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2020
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
William P Tew, Christina Lacchetti, Annie Ellis, et al.
Neurology
|
November 23, 2005
Seizure focus affects regional language networks assessed by fMRI
M M Berl, L M Balsamo, B Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2022
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study
Benoit You, Vasudha Sehgal, Balakrishna Hosmane, et al.
Page
of 143